No evidence for the development of acute analgesic tolerance during and hyperalgesia after prolonged remifentanil administration in mice

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Ishii, Hideaki ^a   Petrenko, Andrey B ^a   Kohno, Tatsuro ^a   Baba, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Analgesia; Continuous infusion; Hyperalgesia; Hypersensitivity; Intraperitoneal; Mechanical thresholds; Mice; Opioid; Remifentanil; Thermal thresholds

Indexed keywords

REMIFENTANIL;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; COOLING; DRUG DOSE ESCALATION; DRUG TOLERANCE; HINDLIMB; HYPERALGESIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; OPIOID TOLERANCE; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; THERMAL THRESHOLD; TISSUE INJURY; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DRUG TOLERANCE; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; PAIN THRESHOLD; PIPERIDINES;

EID: 84874607058     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-11     Document Type: Article

References (41)

1. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008, 24:479-496. 10.1097/AJP.0b013e31816b2f43, 18574358.
2. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570-587. 10.1097/00000542-200603000-00025, 16508405.
3. Benito J, Aguado D, Abreu MB, Garcia-Fernandez J, Gomez de Segura IA. Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat. Br J Anaesth 2010, 105:810-817. 10.1093/bja/aeq241, 20861096.
4. Aguado D, Abreu M, Benito J, Garcia-Fernandez J, Gomez de Segura IA. Ketamine and remifentanil interactions on the sevoflurane minimum alveolar concentration and acute opioid tolerance in the rat. Anesth Analg 2011, 113:505-512.
5. De Segura IA G, De la Vibora JB, Aguado D. Opioid tolerance blunts the reduction in the sevoflurane minimum alveolar concentration produced by remifentanil in the rat. Anesthesiology 2009, 110:1133-1138. 10.1097/ALN.0b013e31819dadaf, 19352151.
6. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002, 94:1263-1269. 10.1097/00000539-200205000-00040, 11973202.
7. Celerier E, Gonzalez JR, Maldonado R, Cabanero D, Puig MM. Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology 2006, 104:546-555. 10.1097/00000542-200603000-00023, 16508403.
8. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000, 92:465-472. 10.1097/00000542-200002000-00029, 10691234.
9. Ishida R, Nikai T, Hashimoto T, Tsumori T, Saito Y. Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats. Anesth Analg 2012, 114:224-229. 10.1213/ANE.0b013e318237f678, 22025495.
10. Crawford MW, Hickey C, Zaarour C, Howard A, Naser B. Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg 2006, 102:1662-1667. 10.1213/01.ane.0000216036.95705.c2, 16717305.
11. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000, 93:409-417. 10.1097/00000542-200008000-00019, 10910490.
12. Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005, 102:398-402. 10.1097/00000542-200502000-00024, 15681957.
13. Lahtinen P, Kokki H, Hynynen M. Remifentanil infusion does not induce opioid tolerance after cardiac surgery. J Cardiothorac Vasc Anesth 2008, 22:225-229. 10.1053/j.jvca.2007.07.004, 18375324.
14. Petersen KL, Jones B, Segredo V, Dahl JB, Rowbotham MC. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers. Anesthesiology 2001, 94:15-20. 10.1097/00000542-200101000-00008, 11135717.
15. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998, 86:1307-1311.
16. Angst MS, Chu LF, Tingle MS, Shafer SL, Clark JD, Drover DR. No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain 2009, 142:17-26. 10.1016/j.pain.2008.11.001, 19135798.
17. Gustorff B, Nahlik G, Hoerauf KH, Kress HG. The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg 2002, 94:1223-1228. 10.1097/00000539-200205000-00032, 11973194.
18. Simonnet G. Acute tolerance to opioids: methodological, theoretical and clinical implications. Pain 2009, 142:3-4. 10.1016/j.pain.2009.01.004, 19167820.
19. Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol 2009, 49:97-121. 10.1146/annurev-pharmtox-061008-103222, 2730377, 18834308.
20. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009, 10:829-839.
21. Davis PJ, Stiller RL, Wilson AS, McGowan FX, Egan TD, Muir KT. In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase. Anesth Analg 2002, 95:1305-1307. 10.1097/00000539-200211000-00038, 12401616.
22. Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CF. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest 2003, 21:682-689. 10.1081/CNV-120023766, 14628425.
23. Petrenko AB, Tsujita M, Kohno T, Sakimura K, Baba H. Mutation of alpha1G T-type calcium channels in mice does not change anesthetic requirements for loss of the righting reflex and minimum alveolar concentration but delays the onset of anesthetic induction. Anesthesiology 2007, 106:1177-1185. 10.1097/01.anes.0000267601.09764.e6, 17525593.
24. Petrenko AB, Yamakura T, Askalany AR, Kohno T, Sakimura K, Baba H. Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor epsilon1 subunit knockout mice. Neuropharmacology 2006, 50:741-747. 10.1016/j.neuropharm.2005.11.019, 16427663.
25. Petrenko AB, Yamakura T, Fujiwara N, Askalany AR, Baba H, Sakimura K. Reduced sensitivity to ketamine and pentobarbital in mice lacking the N-methyl-D-aspartate receptor GluRepsilon1 subunit. Anesth Analg 2004, 99:1136-1140. 10.1213/01.ANE.0000131729.54986.30, 15385364.
26. Cabanero D, Campillo A, Celerier E, Romero A, Puig MM. Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 2009, 111:1334-1345. 10.1097/ALN.0b013e3181bfab61, 19934880.
27. Hayashida M, Fukunaga A, Hanaoka K. Detection of acute tolerance to the analgesic and nonanalgesic effects of remifentanil infusion in a rabbit model. Anesth Analg 2003, 97:1347-1352.
28. Richebe P, Rivalan B, Rivat C, Laulin JP, Janvier G, Maurette P, Simonnet G. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth 2009, 56:126-135. 10.1007/s12630-008-9023-4, 19247760.
29. Aguado D, Abreu M, Benito J, Garcia-Fernandez J, Gomez de Segura IA. The effects of gabapentin on acute opioid tolerance to remifentanil under sevoflurane anesthesia in rats. Anesth Analg 2012, 115:40-45. 10.1213/ANE.0b013e3182542727, 22523419.
30. Aguado D, Abreu M, Benito J, Garcia-Fernandez J, Gomez de Segura IA. Effects of Naloxone on Opioid-induced Hyperalgesia and Tolerance to Remifentanil under Sevoflurane Anesthesia in Rats. Anesthesiology in press.
31. Solt K, Eger EI, Raines DE. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics. Anesth Analg 2006, 102:1407-1411. 10.1213/01.ane.0000204252.07406.9f, 16632818.
32. Tompkins DA, Campbell CM. Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?. Curr Pain Headache Rep 2011, 15:129-136. 10.1007/s11916-010-0171-1, 3165032, 21225380.
33. Petrenko AB, Ishii H, Kohno T, Baba H. When similar is not alike: decreased sensory thresholds after intravenous infusion of remifentanil may not be remifentanil-induced hyperalgesia. Anesth Analg 2012, 115:977.
34. Harris LS, Pierson AK. Some narcotic antagonists in the benzomorphan series. J Pharmacol Exp Ther 1964, 143:141-148.
35. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88. 10.1016/0304-3959(88)90026-7, 3340425.
36. De Camara DL, Raine T, Robson MC. Ultrastructural aspects of cooled thermal injury. J Trauma 1981, 21:911-919. 10.1097/00005373-198111000-00001, 7299859.
37. Demling RH, Mazess RB, Wolberg W. The effect of immediate and delayed cold immersion on burn edema formation and resorption. J Trauma 1979, 19:56-60. 10.1097/00005373-197901000-00011, 762717.
38. Jandera V, Hudson DA, De Wet PM, Innes PM, Rode H. Cooling the burn wound: evaluation of different modalites. Burns 2000, 26:265-270. 10.1016/S0305-4179(99)00133-3, 10741593.
39. King TC, Zimmerman JM. The Effect of Surface Cooling on Heat Penetration in Experimental Burns. Arch Surg 1965, 90:401-403. 10.1001/archsurg.1965.01320090079018, 14247418.
40. Raine TJ, Heggers JP, Robson MC, London MD, Johns L. Cooling the burn wound to maintain microcirculation. J Trauma 1981, 21:394-397. 10.1097/00005373-198105000-00012, 7230286.
41. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957, 111:409-419.